GS-0201
/ Gilead
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 09, 2024
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=248 | Recruiting | Sponsor: Gilead Sciences | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Monotherapy • Oncology • Solid Tumor • Triple Negative Breast Cancer
December 13, 2023
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=248 | Not yet recruiting | Sponsor: Gilead Sciences
New P1 trial • Oncology • Solid Tumor • Triple Negative Breast Cancer
1 to 2
Of
2
Go to page
1